Potential savings from an evidence-based consumer-oriented public education campaign on prescription drugs

Health Services Research

Volumn 43, Issue 5 P1, 2008, Pages 1557-1575

  Donohue, Julie M ^a   Fischer, Michael A ^b   Huskamp, Haiden A ^c   Weissman, Joel S ^d  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Consumer; Costs; Education; Evidence based medicine; Prescription drugs

Indexed keywords

ACEBUTOLOL; ATENOLOL; BENAZEPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CARTEOLOL; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FELODIPINE; FOSINOPRIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LABETALOL; LISINOPRIL; METOPROLOL TARTRATE; MOEXIPRIL; NADOLOL; NIFEDIPINE; PENBUTOLOL; PERINDOPRIL; PINDOLOL; PROPRANOLOL; QUINAPRIL; RAMIPRIL; SOTALOL; TIMOLOL; TRANDOLAPRIL;

ARTICLE; DRUG MARKETING; EVIDENCE BASED PRACTICE; HEALTH EDUCATION; PRESCRIPTION; PUBLIC HEALTH;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR AGENTS; COSTS AND COST ANALYSIS; DRUG UTILIZATION; EVIDENCE-BASED MEDICINE; FEES, PHARMACEUTICAL; HEALTH EDUCATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PRESCRIPTION DRUGS;

EID: 52149117810     PISSN: 00179124     EISSN: 14756773     Source Type: Journal    
DOI: 10.1111/j.1475-6773.2008.00858.x     Document Type: Article

References (57)

1. Adams, A. S., S. B. Soumerai D. Ross-Degnan. 2001 Use of Antihypertensive Drugs by Medicare Enrollees: Does Type of Drug Coverage Matter? Health Affairs 20 (1) : 276 86.
2. Artz, M. B., R. S. Hadsall S. W. Schondelmeyer. 2002 Impact of Generosity Level of Outpatient Prescription Drug Coverage on Prescription Drug Events and Expenditure among Older Persons American Journal of Public Health 92 (8) : 1257 63.
3. Baker, L., T. H. Wagner M. K. Bundorf. 2003 Use of the Internet and E-mail for Health Care Information: Results from a National Survey Journal of the American Medical Association 289 (18) : 2400 6.
4. Banahan, B. F. E. M. Kolassa. 1997 A Physicians Survey on Generic Drugs and Substitution of Critical Dose Medications Archives of Internal Medicine 157 (18) : 2080 8.
5. Catlin, A., C. Cowan, S. Heffler B. Washington. 2007 National Health Spending in 2005: The Slowdown Continues Health Affairs 26 (1) : 142 53.
6. Chobanian, A. V., G. L. Bakris, H. R. Black, W. C. Cushman, L. A. Green, J. L. Izzo, D. W. Jones, B. J. Materson, S. Oparil, J. T. Wright E. J. Roccella. 2003 Joint National Commission on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. National Heart Lung and Blood Institute: National High Blood Pressure Education Program Coordinating Committee Hypertension 42 (6) : 1206 52.
7. Consumer Reports Best Buy Drugs. 2006. "The Statin Drugs: Prescription and Price Trends and Potential Cost Savings in Medicare from Increased Use of Lower-Cost Statins" [accessed on April 24, 2008]. Available at
8. Donohue, J. M., M. Cevasco M. B. Rosenthal. 2007 A Decade of Direct-to-Consumer Advertising of Prescription Drugs New England Journal of Medicine 357 : 673 81.
9. Ellis, J. J., S. R. Erickson, J. G. Stevenson, S. J. Bernstein, R. A. Stiles A. M. Fendrick. 2004 Suboptimal Statin Adherence and Discontinuation in Primary and Secondary Prevention Populations: Should We Target Patients with the Most to Gain? Journal of General Internal Medicine 19 : 638 45.
10. Fillit, H. M., R. Futterman, B. I. Orland, T. Chim, L. Susnow, G. P. Picariello, E. C. Scheye, R. K. Spoeri, J. L. Roglieri S. W. Warburton. 1999 Polypharmacy Management in Medicare Managed Care: Changes in Prescribing by Primary Care Physicians Resulting from a Program Promoting Medication Reviews American Journal of Managed Care 5 (5) : 587 94.
11. Findlay, S. D. 2006 Bringing the DERP to Consumers: 'Consumer Reports Best Buy Drugs.' Health Affairs 25 : W283 6.
12. Fischer, M. A. J. Avorn. 2004a Economic Implications of Evidence-Based Prescribing for Hypertension: Can Better Care Cost Less? Journal of the American Medical Association 291 (15) : 1850 6.
13. Fischer, M. A. J. Avorn. 2004b Potential Savings from Increased Use of Generic Drugs in the Elderly: What the Experience of Medicaid and Other Insurance Programs Means for a Medicare Drug Benefit Pharmacoepidemiology and Drug Safety 13 : 207 14.
14. Fischer, M. A., S. Schneeweiss, J. Avorn D. H. Solomon. 2004 Medicaid Prior-Authorization Programs and the Use of Cyclooxygenase-2 Inhibitors New England Journal of Medicine 351 (21) : 2187 94.
15. Frank, R. 2007 The Ongoing Regulation of Generic Drugs New England Journal of Medicine 357 (20) : 1993 6.
16. Frank, R. G. D. S. Salkever. 1997 Generic Entry and the Pricing of Pharmaceuticals Journal of Economics and Management Strategy 6 (1) : 75 90.
17. Gaither, C. A., D. M. Kirking, F. J. Ascione L. S. Welage. 2001 Consumers' Views on Generic Medications Journal of the American Pharmaceutical Association 41 (5) : 729 36.
18. Gellad, W. F., H. A. Huskamp, K. A. Phillips J. S. Haas. 2006 How the New Medicare Drug Benefit Could Affect Vulnerable Populations Health Affairs 25 (1) : 248 55.
19. Genther, J. M. D. H. Kreling. 2000 Consumer Perceptions of Risk and Required Cost Savings for Generic Prescription Drugs Journal of the American Pharmaceutical Association 40 (3) : 378 83.
20. Gibson, T. B., J. R. Ozminkowski R. Z. Geotzel. 2005 The Effects of Prescription Drug Cost Sharing: A Review of the Evidence American Journal of Managed Care 11 (11) : 730 40.
21. Ginsburg, P. B. 2006. "Statement of Paul Ginsburg, President," Center for Studying Health System Change, Washington, DC.
22. Goldman, D. P., G. E. Joyce, J. Escarce, J. E. Pace, M. D. Solomon, M. Laouri, P. B. Landsman S. M. Teutsch. 2004 Pharmacy Benefits and the Use of Drugs by the Chronically Ill Journal of the American Medical Association 291 (19) : 2344 50.
23. Grimshaw, J. M., L. Shirran, R. Thomas, G. Mowatt, C. Fraser, L. A. Bero, R. Grilli, E. Harvey, A. Oxman M. A. O'Brien. 2001 Changing Provider Behavior: An Overview of Systematic Reviews of Interventions Medical Care 39 (8, suppl 2) : II2 45.
24. Haas, J. S., K. A. Phillips, E. P. Gerstenberger A. C. Seer. 2005 Potential Savings from Substituting Generic Drugs for Brand-Name Drugs: Medical Expenditure Panel Survey, 1997-2000 Annals of Internal Medicine 142 : 891 7.
25. Hartung, D. M., K. L. Ketchum D. G. Haxby. 2006 An Evaluation of Oregon's Evidence-Based Practitioner-Managed Prescription Drug Plan Health Affairs 25 (5) : 1423 32.
26. Hellerstein, J. K. 1998 The Importance of the Physician in the Generic Versus Trade-Name Prescription Decision RAND Journal of Economics 29 (1) : 108 36.
27. Hsu, J., M. Price, J. Huang, R. Brand, V. Fung, R. Hui, B. Fireman, J. Newhouse J. Selby. 2006 Unintended Consequences of Caps on Medicare Drug Benefits New England Journal of Medicine 354 (22) : 2349 459.
28. Hurwitz, M. A. R. E. Caves. 1988 Persuasion or Information? Promotion and the Shares of Brand Name and Generic Pharmaceuticals Journal of Law and Economics XXXI : 299 320.
29. Huskamp, H. A., P. A. Deverka, A. M. Epstein, R. S. Epstein, K. McGuigan R. G. Frank. 2003 The Effect of Incentive-Based Formularies on Prescription-Drug Utilization and Spending New England Journal of Medicine 349 : 2224 32.
30. Iizuka, T. 2004 What Explains the Use of DTCA of Prescription Drugs? Journal of Industrial Economics LII (III) : 349 79.
31. Kravitz, R. L., R. M. Epstein, M. D. Feldman, C. E. Franz, R. Azari, M. S. Wilkes, L. Hinton, P. Franks, R. L. Kravitz, R. M. Epstein, M. D. Feldman, C. E. Franz, R. Azari, M. S. Wilkes, L. Hinton P. Franks. 2005 Influence of Patients' Requests for Direct-to-Consumer Advertised Antidepressants: A Randomized Controlled Trial Journal of the American Medical Association 293 (16) : 1995 2002.
32. Maio, V., L. Pizzi, A. R. Roumm, J. Clarke, N. I. Goldfarb, D. B. Nash D. Chess. 2005 Pharmacy Utilization and the Medicare Modernization Act Milbank Quarterly 83 (1) : 101 30.
33. Medicare Payment Advisory Commission. 2006. "Report to the Congress: Increasing the Value of Medicare" [accessed June 2006]. Available at
34. O'Malley, A. J., R. G. Frank, A. Kaddis, B. M. Rothenberg B. J. McNeil. 2006 Impact of Alternative Interventions on Changes in Generic Dispensing Rates Health Services Research 41 (5) : 1876 94.
35. Pew Charitable Trust Health Information Online 2005. "Pew Internet and American Life Project." Washington, DC: Pew Charitable Trust. Available at
36. Piette, J. D., M. Heisler T. H. Wagner. 2004 Cost-Related Medication Underuse: Do Patients with Chronic Illnesses Tell Their Doctors? Archives of Internal Medicine 164 : 1749 55.
37. Reichert, S., T. Simon E. Halm. 2000 Physicians' Attitudes about Prescribing and Knowledge of the Costs of Common Medication Archives of Internal Medicine 160 : 2799 803.
38. Rosen, A. B., M. B. Hamel, M. C. Weinstein, D. M. Cutler, A. M. Fendrick S. Vijan. 2005 Cost-Effectiveness of Full Medicare Coverage of Angiotensin-Converting Enzyme Inhibitors for Beneficiaries with Diabetes Annals of Internal Medicine 143 : 89 99.
39. Roughead, E. E., F. Zhang, D. Ross-Degnan S. B. Soumerai. 2006 Differential Effect of Early or Late Implementation of Prior Authorization Policies on the Use of Cox II Inhibitors Medical Care 44 (4) : 378 82.
40. Safran, D. G., P. Neuman, C. Schoen, J. E. Montgomery, W. Li, I. B. Wilson, M. S. Kitchman, A. E. Bowen W. H. Rogers. 2002 Prescription Drug Coverage and Seniors: How Well Are States Closing the Gap? Health Affairs Web Exclusives : W253 68.
41. Safran, D. G., P. Newman, C. Schoen, M. S. Kitchman, I. B. Wilson, B. Cooper, A. L. Hong Chang W. H. Rogers. 2005 Prescription Drug Coverage and Seniors: Findings from a 2003 National Survey Health Affairs Web Exclusives (April) : W5-152 66.
42. Saul, S. 2007 Strategies to Avoid Medicare's Big Hole New York Times, New York.
43. Schneeweiss, S., C. Dormuth, P. Grootendorst, S. B. Soumerai M. Maclure. 2004 Net Health Plan Savings from Reference Pricing for Angio-Tensing Converting Enzyme Inhibitors in Elderly British Columbia Residents Medical Care 42 (7) : 653 60.
44. Schneeweiss, S., A. M. Walker, R. J. Glynn, M. Maclure, C. Dormuth S. B. Soumerai. 2002 Outcomes of Reference Pricing for Angiotensing-Converting Enzyme Inhibitors New England Journal of Medicine 346 (11) : 822 9.
45. Shrank, W. H., T. Hoang, S. L. Ettner, P. Glassman, K. Nair, D. DeLapp, J. Avorn S. M. Asch. 2006 The Implications of Choice: Prescribing Generic or Preferred Pharmaceuticals Improves Medication Adherence for Chronic Conditions Archives of Internal Medicine 166 : 332 7.
46. Simon, S. R., H. P. Rodriguez, S. R. Majumdar, K. Kleinman, C. Warner, S. Salem-Schatz, I. Miroshnik, S. B. Soumerai L. A. Prosser. 2007 Economic Analysis of a Randomized Trial of Academic Detailing Interventions to Improve Use of Antihypertensive Medications Journal of Clinical Hypertension 9 (1) : 15 20.
47. Soumerai, S. B., M. Pierre-Jacques, F. Zhang, D. Ross-Degnan, A. S. Adams, J. Gurwitz, G. Adler D. G. Safron. 2006 Cost-Related Medication Nonadherence among Elderly and Disabled Medicare Beneficiaries Archives of Internal Medicine 166 : 1829 35.
48. Spinewine, A., K. Schmader, N. Barber, C. Hughes, K. L. Lapane J. T. Hanlon. 2007 Appropriate Prescribing in Elderly People: How Well Can It Be Measured and Optimised? Lancet 370 : 173 84.
49. Stuart, B., B. A. Briesacher, D. G. Shea, B. Cooper, F. S. Baysac R. Limcangco. 2005a Riding the Rollercoaster: The Ups and Downs in Out-of-Pocket Spending under the Standard Medicare Drug Benefit Health Affairs 24 (4) : 1022 31.
50. Stuart, B., L. Simoni-Wastila D. Chancey. 2005b Assessing the Impact of Coverage Gaps in the Medicare Part D Drug Benefit Health Affairs W5 : 167 79.
51. Suh, D. C., W. G. Manning, S. Schondelmeyer R. S. Hadsall. 2000 Effect of Multiple-Source Entry on Price Competition after Patent Expiration in the Pharmaceutical Industry Health Services Research 35 (2) : 529 47.
52. Thom, T., N. Haase, W. Rosamong, V. J. Howard, J. Rumsfeld, T. Manolio, Z-J. Zheng, K. Flegal, C. O'Donnell, S. Kittner, D. Lloyd-Jones, D. C. Goff Jr., Y. Hong, Members of the Statistics Committee and Stroke Statistics Subcommittee, R. Adams, G. Friday, K. Furie, P. Gorelick, B. Kissela, J. Marler, J. Meigs, V. Roger, S. Sidney, P. Sorlie, J. Steinberger, S. Wasserthiel-Smoller, M. Wilson P. Wolf. 2006 Heart Disease and Stroke Statistics - 2006 Update: A Report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 113 : 85 151.
53. Tseng, C., R. H. Brook, E. Keeler C. M. Mangione. 2003 Impact of an Annual Dollar Limit or 'Cap' on Prescription Drug Benefits for Medicare Patients Journal of the American Medical Association 290 (2) : 222 7.
54. Voelker, R. 2005 Easy-to-Use Drug Reports Help Patients and Physicians Weigh Costs, Benefits Journal of the American Medical Association 294 (2) : 165 6.
55. Winkelmayer, W. C., M. A. Fischer, S. Schneeweiss, P. S. Wang, R. Levin J. Avorn. 2005 Underuse of ACE Inhibitors and Angiotensin II Receptor Blockers in Elderly Patients with Diabetes American Journal of Kidney Diseases 46 (6) : 1080 7.
56. Zorowitz, B. J., L. A. Stebelsky, B. K. Muma, T. M. Romain E. L. Peterson. 2005 Reduction of High-Risk Polypharmacy Drug Combinations in Patients in a Managed Care Setting Pharmacotherapy 25 (11) : 1636 45.
57. Zuvekas, S. H. J. W. Cohen. 2007 Prescription Drugs and the Changing Concentration of Health Care Expenditures Health Affairs 26 (1) : 249 57.